[Adverse effects of antiepileptic agents].
Nakken
K O
KO
Statens senter for epilepsi, Sandvika. karl.otto.nakken@epilepsy.no
Johannessen
S I
SI
Rytter
E
E
D000085:Acetates / Q000009:adverse effects; D000588:Amines; D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects*; D001569:Benzodiazepines; D000078306:Clobazam; D003509:Cyclohexanecarboxylic Acids; D004363:Drug Utilization; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives; D000077206:Gabapentin; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects; D000077213:Lamotrigine; D000077287:Levetiracetam; D009557:Nipecotic Acids / Q000009:adverse effects; D009664:Norway; D010889:Piracetam / Q000009:adverse effects / Q000031:analogs & derivatives; D000078308:Tiagabine; D000077236:Topiramate; D014227:Triazines / Q000009:adverse effects; D020888:Vigabatrin / Q000009:adverse effects; D000078305:Zonisamide; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D007555:Isoxazoles; D009557:Nipecotic Acids; D014227:Triazines; D000077236:Topiramate; D001569:Benzodiazepines; D000078306:Clobazam; D005632:Fructose; D000077287:Levetiracetam; D000078305:Zonisamide; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D020888:Vigabatrin; D000077213:Lamotrigine; D000078308:Tiagabine; D010889:Piracetam